期刊文献+

孟鲁司特钠联合布地奈德气雾剂治疗儿童哮喘的临床观察 被引量:3

Clinical Observation of Montelukast Sodium United Cloth Budesonide Aerosol Treatment of Asthma in Children
下载PDF
导出
摘要 目的研究孟鲁司特钠以及布地奈德气雾剂治疗儿童哮喘的疗效。方法选择本院门诊和住院部儿童哮喘80例,随机分成治疗组和对照组,每组40例。治疗组在吸入布地奈德气雾剂400μg/d基础上加孟鲁司特钠咀嚼片,5mg/d,每晚顿服,共3月,并随访3个月。观察期间如有哮喘急性发作,加用β2受体激动剂。对照组除不用孟鲁司特钠咀嚼片外,其余与治疗组相同。结果治疗组每月日间、夜间发作次数、用β2受体激动剂的次数较对照组明显减轻,差异有统计学意义(P<0.01)。治疗组FEV1占预计值的百分比较对照组改善明显,差异有统计学意义(P<0.01)。观察期间暂无不良反应发生。结论孟鲁司特钠联合布地奈德气雾剂治疗儿童哮喘疗效优于单纯使用布地奈德气雾剂,可适用于经正规治疗而疗效不佳患儿。 Objective To investigate the curative effect of montelukast sodium and budesonide aerosol of childhood asthma. Methods To choose outpatient and inpatient hospital 80 cases of children with asthma were randomly divided into treatment group and control group, each 40 cases. Treatment group inhaled budesonide 400μg/d based on Jiameng Lu Division special sodium chewable tablets, 5 rag/d, per night serving Dayton, 3 months, and follow-up in March. The observation period is subject to acute asthma attacks, plus β2 agonists. Control group montelukast sodium chewable tablets do not have the rest with the same treatment group.Results In the treatment group, the times of asthma spasm and dyspnea in the night and the days, and the times of using short effective β2 adrenocept or agonist were less than in the control group, there were marked difference between two groups (P〈0.01). In the treatment group, the rate of ameliorated FEVt were better than those in the control group, there were marked difference between two groups (P〈0.01), and the adverse effects were reduced. Conelusion Montelttkast sodium connecting with budesonide curing childish asthma have powerful effect, which is better than that only by imbibing glucocorticoid. It can become a good method curing to those children, who used regular treatment but the treatment is not ideal.
作者 蔡正维
出处 《中国医药指南》 2012年第27期404-406,共3页 Guide of China Medicine
关键词 孟鲁司特钠 布地奈德 儿童哮喘 Montelukast sodium Budesonide Childhood asthma
  • 相关文献

参考文献9

二级参考文献52

  • 1袁晓梅,郭悦鹏.转化生长因子β1与哮喘的相关性及川芎嗪治疗哮喘的研究进展[J].新乡医学院学报,2006,23(2):207-209. 被引量:26
  • 2邓火金,孙滨.糖皮质激素对哮喘患者CD_4T淋巴细胞和嗜酸细胞活化的影响[J].中华内科杂志,1997,36(1):7-10. 被引量:5
  • 3中华医学会耳鼻咽喉科学分会.变应性鼻炎诊断标准及疗效评定标准[J].中华耳鼻咽喉科杂志,1998,33(3):134-134.
  • 4Lagos JA, Marshall GD. Montelukast in the management of allergic rhinitis [ J ]. Ther Clin Risk Manag ,2007 ,3 (2) :327 - 332.
  • 5Nayak A, Langdon RB. Montelukast in the treatment of allergic rhinitis : An evidence - based review[ J]. Drugs ,2007,67 (6) :887 - 901.
  • 6Nayak A. A review of montelukast in the treatment of asthma and allergic rhinitis[J]. Expert Opin Pharmacother,2004,5 (3) :679 - 686.
  • 7Bousquet J, Khahaev N, Cruz AA, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 Update (in collaboration with the world health organization, GALEN and AllerGen) [ J]. Allergy,2008,63 ( snppl 86 ) : 8 - 160.
  • 8Cowburn AS, Holgate ST, SamPson AP, et al. IL - 5 inereases expression of 5 - lipoxygenase to the nucleus in human blood eosinophils [ J ]. Immunology, 1999,163 ( 1 ) :456 - 465.
  • 9Kom D, van den Brande P, Potvin E, et al. Efficacy of add - on monte- lukast in patients with non - controlled asthma : A Belgian open - label study[ J]. Curr Med Res Opin ,2009,25 (2) :489 -497.
  • 10Wahn U, Dass SB. Review of recent results of montelukast use as a monotherapy in children with mild asthma [ J ]. Clin Therap, 2008,30 (3) :1026 - 1035.

共引文献3239

同被引文献20

  • 1余洽超,余明杰,麦劲刚,戴上康,周逢洽.孟鲁司特钠与吸入布地奈德联合治疗儿童哮喘的临床观察[J].中国现代应用药学,2007,24(3):249-250. 被引量:15
  • 2李万鹏.布地奈德联合特布他林雾化吸入治疗小儿哮喘急性发作疗效分析[J].药物与临床,2012,2(14):69-70.
  • 3Bush A. Montelukast in paediatric asthma: where we arenow and what still needs to be done?[J]. Paediatr RespirRev, 2015, 16(2): 97-100.
  • 4Stanford RH, Shah M, Chaudhari SL. Clinical andeconomic outcomes associated with low-dose fluticasonepropionate versus montelukast in children with asthma aged4 to 11 years[J]. Open Respir Med J, 2012, 6: 37-43.
  • 5Massingham K, Fox S,Smaldone A. Asthma therapy inpediatric patients: a systematic review of treatment withmontelukast versus inhaled corticosteroids[J]. J PediatrHealth Care, 2014, 28(1): 51-62.
  • 6Straub DA, Moeller A, Minocchieri S, et al. The effect ofmontelukast on lung function and exhaled nitric oxide ininfants with early childhood asthma[J]. Eur Respir J, 2005,25(2): 289-294.
  • 7Miraglia del Giudice M, Piacentini GL, Capasso M, et al.Formoterol, montelukast, and budesonide in asthmaticchildren: effect on lung function and exhaled nitricoxide[J]. Respir Med, 2007, 101(8): 1809-1813.
  • 8儿童支气管哮喘诊断与防治指南[J].中华儿科杂志,2008,46(10):745-753. 被引量:2510
  • 9邓伟吾.吸入性糖皮质激素治疗支气管哮喘[J].临床肺科杂志,2009,14(2):143-144. 被引量:31
  • 10李莉.孟鲁司特联合布地奈德治疗儿童支气管哮喘效果观察[J].临床误诊误治,2009,22(2):40-41. 被引量:44

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部